273.56MMarket Cap
LossP/E TTM
MYGN Balance Sheet
You can check out the annual or quarterly balance sheets of Myriad Genetics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing MYGN stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Myriad Genetics Inc Have?
In its most recent quarterly, Myriad Genetics Inc had 115.20M in cash and cash equivalents.
How Much Are Myriad Genetics Inc's Total Liabilities?
Myriad Genetics Inc reported 338.60M in total liabilities as of the latest reported quarter, including 133.80M in current liabilities and 204.80M in non-current liabilities.
What Are Myriad Genetics Inc's Total Assets?
As of the latest reported quarter, Myriad Genetics Inc's total assets were 706.60M, consisting of 332.60M in current assets and 374.00M in non-current assets.
How Much Shareholders' Equity Does Myriad Genetics Inc Have?
Myriad Genetics Inc reported 368.00M in total shareholders' equity as of the latest reported quarter.